Alder Biopharmaceuticals Inc (ALDR)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
24-Oct-19 7:17 PM
View: 
Redmile Group, LLC
Director
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Disposition (change in control) 8,244,900----(100%)
8.24M to 0
24-Oct-19 7:09 PM
View: 
Hassler Randal
EVP, Pharmaceutical Ops.
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Grant 14,346----264%
5.43K to 19.78K
24-Oct-19 7:28 PM
View: 
Streck Paul
Chief Medical Officer
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Disposition 1,390$18.00$25,020.00(100%)
1.39K to 0
24-Oct-19 7:07 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Disposition 21,502$18.00$387,036.00(100%)
21.5K to 0
24-Oct-19 6:58 PM
View: 
Montgomery Alan Bruce
Director
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Disposition (change in control) 9,628$18.00$173,304.00(100%)
9.63K to 0
24-Oct-19 7:03 PM
View: 
Siegall Clay B
Director
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Disposition (change in control) 31,714$18.00$570,852.00(100%)
31.71K to 0
24-Oct-19 7:05 PM
View: 
Yarno Wendy L
Director
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Disposition (change in control) 5,000$18.00$90,000.00(100%)
5.0K to 0
24-Oct-19 7:09 PM
View: 
Hassler Randal
EVP, Pharmaceutical Ops.
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Disposition 19,780$18.00$356,040.00(100%)
19.78K to 0
24-Oct-19 7:10 PM
View: 
Bucher James B
EVP & General Counsel
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Disposition (change in control) 27,677$18.00$498,186.00(100%)
27.68K to 0
24-Oct-19 7:07 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Grant 16,230----308%
5.27K to 21.5K
24-Oct-19 7:12 PM
View: 
Lavelle Erin
Chief Operating Officer
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Disposition (change in control) 16,092$18.00$289,656.00(100%)
16.09K to 0
24-Oct-19 7:10 PM
View: 
Bucher James B
EVP & General Counsel
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Grant 15,619----130%
12.06K to 27.68K
24-Oct-19 7:12 PM
View: 
Lavelle Erin
Chief Operating Officer
Alder Biopharmaceuticals Inc (ALDR) 22-Oct-19Grant 11,684----265%
4.41K to 16.09K
24-Oct-19 7:10 PM
View: 
Bucher James B
EVP & General Counsel
Alder Biopharmaceuticals Inc (ALDR) 11-Oct-19Grant 904$9.20$8,316.808%
11.15K to 12.06K
24-Oct-19 7:28 PM
View: 
Streck Paul
Chief Medical Officer
Alder Biopharmaceuticals Inc (ALDR) 11-Oct-19Grant 1,390$9.20$12,788.00100%
0 to 1.39K
18-Sep-19 4:45 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 16-Sep-19Option Exercise 32,728$4.15$135,902.00621%
5.27K to 38.0K
18-Sep-19 4:45 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 16-Sep-19Planned Private Option Sale 32,728$18.44$603,504.00(86%)
38.0K to 5.27K
24-Oct-19 7:10 PM
View: 
Bucher James B
EVP & General Counsel
Alder Biopharmaceuticals Inc (ALDR) 31-May-19Grant 1,345$9.20$12,370.0014%
9.81K to 11.15K
25-Apr-19 6:43 PM
View: 
Bucher James B
EVP & General Counsel
Alder Biopharmaceuticals Inc (ALDR) 25-Apr-19Market Sale (Planned) 1,897$13.85$26,280.80(16%)
11.71K to 9.81K
25-Apr-19 6:49 PM
View: 
Lavelle Erin
Chief Operating Officer
Alder Biopharmaceuticals Inc (ALDR) 25-Apr-19Market Sale (Planned) 1,434$13.67$19,599.30(25%)
5.84K to 4.41K
25-Apr-19 6:53 PM
View: 
Benedict Larry
EVP and PAO
Alder Biopharmaceuticals Inc (ALDR) 25-Apr-19Market Sale (Planned) 1,734$13.65$23,662.20(4%)
41.46K to 39.73K
25-Apr-19 6:55 PM
View: 
Hassler Randal
EVP, Pharmaceutical Ops.
Alder Biopharmaceuticals Inc (ALDR) 25-Apr-19Market Sale (Planned) 1,738$13.85$24,067.00(24%)
7.17K to 5.43K
25-Apr-19 6:51 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 25-Apr-19Disposition 4,847$13.73$66,525.60(48%)
10.12K to 5.27K
25-Apr-19 6:51 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 23-Apr-19Grant 9,288----1118%
0.83K to 10.12K
25-Apr-19 6:53 PM
View: 
Benedict Larry
EVP and PAO
Alder Biopharmaceuticals Inc (ALDR) 23-Apr-19Grant 7,055----21%
34.41K to 41.46K
25-Apr-19 6:49 PM
View: 
Lavelle Erin
Chief Operating Officer
Alder Biopharmaceuticals Inc (ALDR) 23-Apr-19Grant 5,842----100%
0 to 5.84K
25-Apr-19 6:43 PM
View: 
Bucher James B
EVP & General Counsel
Alder Biopharmaceuticals Inc (ALDR) 23-Apr-19Grant 7,810----200%
3.9K to 11.71K
25-Apr-19 6:55 PM
View: 
Hassler Randal
EVP, Pharmaceutical Ops.
Alder Biopharmaceuticals Inc (ALDR) 23-Apr-19Grant 7,172----100%
0 to 7.17K
06-Mar-19 4:24 PM
View: 
Redmile Group, LLC
Director
Alder Biopharmaceuticals Inc (ALDR) 04-Mar-19Grant 1,739,130$11.50$20,000,000.0027%
6.51M to 8.24M
11%
04-Dec-18 6:39 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 03-Dec-18Option Exercise 5,044$0.99$4,993.56607%
0.83K to 5.88K
04-Dec-18 6:39 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 03-Dec-18Market Option Sale (Planned) 5,044$13.84$69,826.10(86%)
5.88K to 0.83K
(3%)
08-Feb-19 4:41 PM
View: 
Benedict Larry
EVP and PAO
Alder Biopharmaceuticals Inc (ALDR) 30-Nov-18Grant 954$9.35$8,919.903%
33.45K to 34.41K
08-Feb-19 4:47 PM
View: 
Latham John A
Chief Scientific Officer
Alder Biopharmaceuticals Inc (ALDR) 30-Nov-18Grant 487$9.35$4,553.45< 1%
243.69K to 244.18K
08-Feb-19 4:43 PM
View: 
Bucher James B
EVP & General Counsel
Alder Biopharmaceuticals Inc (ALDR) 30-Nov-18Grant 273$9.35$2,552.558%
3.62K to 3.9K
05-Nov-18 5:43 PM
View: 
Latham John A
Chief Scientific Officer
Alder Biopharmaceuticals Inc (ALDR) 01-Nov-18Option Exercise 25,002$9.12$227,954.0010%
243.69K to 268.69K
05-Nov-18 5:43 PM
View: 
Latham John A
Chief Scientific Officer
Alder Biopharmaceuticals Inc (ALDR) 01-Nov-18Market Option Sale (Planned) 25,002$13.42$335,589.00(9%)
268.69K to 243.69K
(7%)
05-Nov-18 5:47 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 01-Nov-18Option Exercise 5,040$0.99$4,989.60606%
0.83K to 5.87K
05-Nov-18 5:47 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 01-Nov-18Market Option Sale (Planned) 5,040$13.42$67,636.80(86%)
5.87K to 0.83K
(7%)
03-Oct-18 6:33 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 01-Oct-18Option Exercise 5,040$0.99$4,989.60606%
0.83K to 5.87K
03-Oct-18 6:33 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 01-Oct-18Market Option Sale (Planned) 5,040$15.54$78,329.40(86%)
5.87K to 0.83K
8%
03-Oct-18 6:31 PM
View: 
Latham John A
Chief Scientific Officer
Alder Biopharmaceuticals Inc (ALDR) 01-Oct-18Option Exercise 24,999$4.36$109,108.0010%
243.69K to 268.69K
03-Oct-18 6:31 PM
View: 
Latham John A
Chief Scientific Officer
Alder Biopharmaceuticals Inc (ALDR) 01-Oct-18Market Option Sale (Planned) 24,999$15.44$386,006.00(9%)
268.69K to 243.69K
7%
06-Sep-18 5:05 PM
View: 
Latham John A
Chief Scientific Officer
Alder Biopharmaceuticals Inc (ALDR) 04-Sep-18Option Exercise 24,999$3.46$86,621.5010%
243.69K to 268.69K
06-Sep-18 5:05 PM
View: 
Latham John A
Chief Scientific Officer
Alder Biopharmaceuticals Inc (ALDR) 04-Sep-18Market Option Sale (Planned) 24,999$17.99$449,680.00(9%)
268.69K to 243.69K
20%
06-Sep-18 5:08 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 04-Sep-18Option Exercise 5,040$0.99$4,989.60606%
0.83K to 5.87K
06-Sep-18 5:08 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 04-Sep-18Market Option Sale (Planned) 5,040$18.00$90,698.80(86%)
5.87K to 0.83K
20%
02-Aug-18 5:40 PM
View: 
Latham John A
Chief Scientific Officer
Alder Biopharmaceuticals Inc (ALDR) 01-Aug-18Option Exercise 24,999$3.46$86,621.5010%
243.69K to 268.69K
02-Aug-18 5:40 PM
View: 
Latham John A
Chief Scientific Officer
Alder Biopharmaceuticals Inc (ALDR) 01-Aug-18Market Option Sale (Planned) 24,999$19.55$488,768.00(9%)
268.69K to 243.69K
27%
02-Aug-18 5:48 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 01-Aug-18Option Exercise 5,040$0.99$4,989.60606%
0.83K to 5.87K
02-Aug-18 5:48 PM
View: 
Smith Jeffrey T L
Managing Director
Alder Biopharmaceuticals Inc (ALDR) 01-Aug-18Market Option Sale (Planned) 5,040$19.54$98,489.00(86%)
5.87K to 0.83K
27%